As Natalia states, “viral vector manufacture has come a long way, but the story is far from over”.
You can check the interview here: https://themedicinemaker.com/manufacture/two-steps-forward-more-steps-to-go
Posted on 4 May 2022
Interview with Natalia Elizalde in The Medicine Maker
The Business Development Director of VIVEbiotech Dr. Natalia Elizalde was interviewed by The Medicine Maker on the challenges of lentiviral vector manufacture/use.
